Opaleye Management Inc. - Q4 2010 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2010
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CODEXIS INC42Q2 202410.9%
CHIMERIX INC31Q3 202216.4%
XOMA CORP DEL30Q2 20243.6%
OCULAR THERAPEUTIX INC27Q2 202417.6%
FIBROGEN INC26Q1 20216.8%
BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019)26Q1 20202.4%
ETON PHARMACEUTICALS INC23Q2 20245.6%
AXOGEN INC20Q4 201918.7%
TG THERAPEUTICS INC20Q2 202410.1%
CRINETICS PHARMACEUTICALS INC20Q1 20245.6%

View Opaleye Management Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Opaleye Management Inc. Q4 2010 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
iBio, Inc.April 09, 2024650,0007.6%
OCULAR THERAPEUTIX, INCFebruary 14, 20246,070,0005.5%
SANUWAVE Health, Inc.February 14, 2024115,493,5549.1%
HARROW, INC.February 09, 20243,820,00010.9%
Jounce Therapeutics, Inc.Sold outFebruary 09, 202400.0%
Tracon Pharmaceuticals, Inc.February 09, 2024100.0%
Context Therapeutics Inc.January 05, 2024820,0005.1%
CHIMERIX INCSold outFebruary 13, 202300.0%
Larimar Therapeutics, Inc.January 23, 20231,560,0003.6%
TELA Bio, Inc.June 10, 20221,557,50010.7%

View Opaleye Management Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-09-26
42024-09-23
42024-09-19
SC 13G/A2024-09-18
32024-09-12
42024-09-12
42024-09-12
SC 13G/A2024-09-12
42024-09-10
N-PX2024-09-03

View Opaleye Management Inc.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Opaleye Management Inc.'s holdings

CSVXLS